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Introduction
In porphyrias, hereditary enzyme deficiency can
be recognized in the red blood cells. Four enzymes of
hema biosynthesis can be detected: porphobilinogen
synthase (delta-aminolevulinic acid dehydrase), uroporphyrinogen synthase, cosynthas and decarboxylase.
A decrease of porphobilinogen synthase observes in
lead intoxication. Uroporphyrinogen cosynthase decreases in congenital erythropoietic porphyria. Acute
intermittent porphyria is characterized by deficient
uroporphyrinogen synthase. Uroporphyrinogen decarboxylase decreases in the genetic type of porphyria
cutunea tarda (1)
Hepatoerythropoietic porphyria (HEP) is a rare
homozygous variant of porphyria cutunea tarda, autosomal recessive disorder due to deficient hepatic uroporphyrinogen decarboxylase enzyme activity (2). We
reported a 5-year old boy who had the clinical and biochemical findings of HEP. Brain tomography revealed
hydrocephalus and subarachnoidal cyst. Central nervous
system abnormalities are a rare feature in association
with HEP.
A 5-year old boy, was hospitalized with photosensitivity, red colour urine, hypertrichosis and hyperpigmentation particularly on his face and all body surfaces; The brownish wounds on his face, and hands
healed with white scars (fig 1). These features were
first appeared three years ago. He was delivered after
an uneventful pregnancy, and normal labor. All the
family member were healthy and there was no history
of illness. The parents were not relatives. On physical
examination, the head circumference was 50 cm (90
p), the weight 19.2 kg (50-75 p) and the length 106
cm (25 p). Blood pressure ws 100/60 mmHg, the
breath 26/minute, and the pulse 132/minute. The patient was considered as mentally retarded because of

Figure 1.

Brownish wounds of on his face and hand healing with
white scars and hypertrichosis on his face are seen.

the apperance and behaviours, but the age of the patient was too small for performing the intelligence
test. Liver was 2 cm palpable and liver biopsy showed
nonspecific changes. Spleen was nonpalpable. Laboratory findings: Hb 9.3 gr./dl, WBC 6400/mm3,
thrombocyt 359000/mm3, AST 170 U/L, ALT 214 U/L
alkaline phosphatase 349 U/L total protein 7.9gr./dl,
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HEP has typical cutaneous manifestations: photosensitiity with blistering and mild scarring and hypertrichosis (4). Our patient had hyperpigmentation particularly on his face and all of body surface brownish
wounds on his face and hand healing with white scars
and hypertrichosis on his face.

Figure 2.

Brain
tomography
subarachnoidal cyst.

reveals

hydrocephalus

and

albumin 3.9 gr./dl, total biluribine 0.35 mg/dl, direct
bilirubine 0.20 mg/dl the makers of the hepatitis A, B,
C and D were negatives, serum iron 33 µg/dl aminolaevulinic acid 15 mmol/L (0-40), porphobilinogen 10
mmol/L (0-16), uroporphyrin 500 nmol/L (0-40), coproporphyrin 6985 nmol/L (0-370). Brain tomography
revealed hydrocephalus and subarchnoidal cyst. (Fig.2)
Porphyrias are either hepatic or erythroid, depending on the specific enzymatic defect. Hepatoerythropoietic porphyria (HEP) is the resulting
from a deficiency of homozygous hepatic uroporphyrinogen decarboxylase activity, an enzyme that
is essential for hema biosynthesis. The condition is extremely rare in children. Most cases of childhood HEP
are familial, severe, and commonly associated with liver disease and hepatic iron overload (3). In our case,
biochemically elevated levels of uroporphyrines in urine
and coproporphyrins in feaces are markers of this
form of porphyria. Serum iron level was normal, serum transaminase levels were elevated and liver biopsy
showed nonspecific changes. All family members of the
patient were healthy.

Protoporphyrin overproduction occures in erytroid
tissue. The release of protoporphyrin from erytrocytes
is greatly increased if the erythrocytes are exposed to
light. The cutaneous symptoms are related by protoporphyrin-sensitized photodamage of endothelial cellls.
Endothelial cells accumulated protoporphyrin from albumin or lipoproteins present in the plasma. Uroporphyrin and coproporphyrin are hydrophilic and are
unbound in plasma. In hepatic and erythropoietic porphyrias, clinical symptoms are probably evoked by uroporphyrin and coproporphyrin present in the interstitial tissue. Very little is know about the primary
targets of uroporphyrin and coroporphyrin photodamage in these disorders (5).
Central nervous system abnormalities have been
previously reported in association with HEP (2) but
there are rare features. In our case, brain totography
revealed hydrocephalus and subarachnoidal cyst.
HEP is controlled by removal of iron by phlebotomies or with lowdose chloroquine. Skin symptoms
in porphyria can be reduced with beta caroten there is
no effective treatment in congenital porphyria but suggested that bone marrow transppantation (6,7). Caudry performed gene transferred in Congenital erythropoetic porphiria (8). Serum iron levels was normal
and liver biopsy showed nonspecific changes in our patient. We didn’t use betacaroten for skin symptoms.
Eleven patients with HEP have been reported until
1984 (9). This case was found interesting because of
the rare occurrence of HEP and very rare presentation
of it with central nervous system abnormalities.
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